The US Supreme Court recently issued a temporary stay on ensuring that a common abortion pill would remain widely available while the Supreme Court decides whether to grant a formal stay.
The interim stay will expire at midnight on Wednesday.
Further, in order to give justices a little more time to think about the pertinent concerns, Justice Samuel Alito granted the government’s request for an emergency stay and stated that the whole court will make a judgment here by Wednesday.
Notably, the Supreme Court put a hold on the lower court’s decision to revoke the authorization of mifepristone, one of the drugs used in roughly half of all US abortions.
The organizations contesting the Food and Drug Administration’s clearance of the pill were required to submit their brief by Tuesday at noon, according to Judge Alito, the court is officially in charge of supervising the appeals court whose decision is in question.
Therefore, the action was taken in response to an emergency application the Biden administration submitted Friday morning requesting the justices to get involved.
The US Food and Drug Administration (FDA) recently permitted the mailing and distribution of mifepristone to patients between 7-10 weeks of pregnancy, but that appeals court nevertheless placed various restrictions on its use.
According to the sources, the Supreme Court’s decision to reverse Roe v Wade last June, which ended the US Constitution’s protection of the right to an abortion, the anti-abortion rights organizations have turned their attention to the availability of abortion drugs like mifepristone.
Since then, other states governed by the Republicans have imposed extensive abortion restrictions.
Previously, a federal judge in Texas granted an order that would have momentarily halted the FDA’s approval of mifepristone while he reviewed legal arguments regarding the availability of the medication.
However, the judge postponed his decision for seven days to enable the federal government to file an appeal.
A federal court in Washington state issued its ruling less than 2 hours later, saying the FDA must maintain access to abortion medications in more than a dozen states with Democratic governors.
